| Vaccine | Indication |
|---|---|
| Hepatitis A | All susceptible people with HIV; single preparation (Twinrix) available if administering with a hepatitis B vaccine |
| Hepatitis B* | All susceptible people with HIV Not required if: hepatitis B surface antibody and core antibodies are both positive or Hepatitis B surface antibody is positive after a previous complete vaccine series See guidelines for serologic scenarios, immunization schedules, and preparations (e.g., two- or three-dose series)† |
| Herpes zoster | Recombinant zoster vaccine (Shingrix) recommended for people ≥ 50 years |
| Human papillomavirus | Standard schedule; if not fully immunized, a catch-up immunization is indicated through 26 years of age; shared decision-making for 27 to 45 years of age |
| Influenza (inactivated only) | Standard schedule; high dose usually recommended; live attenuated influenza vaccine contraindicated |
| Meningococcal | All people with HIV |
| Pneumococcal | All people with HIV‡ |
| Tetanus toxoid, reduced diphtheria toxoid, acellular pertussis (Tdap) | Standard schedule |